Targeted therapies expanding treatment options in metastatic thyroid cancer

Rodrigo Arrangoiz MS, MD, FACS, FSSO

👉Targeted therapies are expanding treatment options in metastatic thyroid cancer (MTC).

👉In the past 10 years, four VEGF inhibitors have been approved for MTC: sorafenib and lenvatinib for differentiated thyroid cancer, and cabozantinib and vandetanib for medullary thyroid cancer.

👉Cabozantinib and vandetanib are also moderate RET inhibitors.

👉In addition, larotrectinib was recently approved for all solid tumors that harbor TRK fusions, and patients with differentiated thyroid cancer are frequently TRK positive.

👉Consequently, knowing what genetic mutations a patient harbors can greatly affect the choice of therapies.

#Arrangoiz #ThyroidSurgeon #ThyroidExpert #CASO #CenterforAdvancedSurgicalOncology #PalmettoGeneralHospital

Unknown's avatar

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

Leave a comment